Surviving COVID-19: A new model to stop deaths

by Elizabeth Lee Vliet, M.D.
Posted 9/23/20

The COVID death rate in the United States is one of the highest in the world, even with our advanced medical care delivery and resources. Many less affluent countries have death rates 20 times lower …

This item is available in full to subscribers.

Please log in to continue

E-mail
Password
Log in

Surviving COVID-19: A new model to stop deaths

Posted

The COVID death rate in the United States is one of the highest in the world, even with our advanced medical care delivery and resources. Many less affluent countries have death rates 20 times lower than the U.S., even with fewer hospitals, doctors, nurses and high tech equipment.
What is the common factor that accounts for the marked difference in death rates?
It is quite simply this: Other countries use early outpatient treatment with widely available antiviral medicines, begun at the first signs of symptoms, usually without waiting extra days for test results to confirm the physician’s clinical diagnosis.
The late stage treatment model promoted by Dr. Fauci and FDA’s Dr. Hahn has been for U.S. patients to be sent home to self-quarantine until symptoms worsened, and then go into the hospital when seriously ill with respiratory distress and heart damage. Only then do patients get offered medication, oxygen support, steroids, anti-coagulants, and others that typically don’t work as well at this critical illness stage.
But home therapy could prevent thousands of hospitalizations and deaths, according to a just-published article from the respected American Journal of Medicine. The U.S. urgently needs to implement this early successful model. Lead author Peter McCullough, M.D., a cardiologist at Baylor, one of the most widely published physicians in America,is not just theorizing. He is actually treating COVID patients at home.
Dr. McCullough’s recommendation would clearly save lives using cheap, safe, FDA-approved medicines—hydroxychloroquine (HCQ) with azithromycin or doxycycline, possibly ivermectin or colchicine, inhaled budesomide or oral steroids, home oxygen concentrators, plus supplemental zinc, vitamin C and vitamin D.
The supply of HCQ has been ramped up to handle its use in early treatment of COVID, but we have millions of doses in the Strategic National Stockpile deteriorating in government warehouses—vital medicine that is not being distributed because, for political reasons, doctors are still not prescribing for COVID-19 outpatients.
Why don’t Americans have the freedom to use HCQ as in other countries? FDA’s false narrative about HCQ causing harm to outpatients has led to more deaths with unprecedented restrictions on physicians’ off-label prescribing rights imposed by state governors, medical boards and pharmacy boards. Thirty-seven states still restrict HCQ.
There are other major forces pushing against home-based treatment that have resulted in our high death rate. These coordinated efforts are amplified by the main stream media megaphone perpetuating the constant drum beat of fear to keep the public afraid of returning to normal activities.
The hospital lobby is preventing outpatient treatment to maintain hospital income. The issues raised in Avik Roy’s classic 2013 review have been made worse during the COVID-19 pandemic because hospitals received significantly higher payments for COVID patients, especially those who go on a ventilator.
Big Pharma pushes for new high-cost medicines still on patent—for example, Gilead’s major push to discredit HCQ and favor remdesivir, its costly experimental drug.
Enormous financial conflicts exist within the NIH, CDC and FDA –all of whom get payments from pharmaceutical companies and vaccine manufacturers, as well as income from patents on new vaccine adjuvants and processes. Dr. McCullough’s editorial, “The Great Gamble of Covid-19 Vaccine Development,” explained this multibillion-dollar financial incentive to preserve vaccine windfall profits in wealthy countries.
Big Medicine, as shown clearly by the AMA’s actions to falsely malign HCQ, no longer advocates for physicians and patients, but works to protect its revenue from government contracts.
Academic medical centers all have research programs dependent on NIH grants. Many academic physicians have been “muzzled” by their institutions from speaking out because of threatened loss of funding.
In contrast, the forces pushing for early, home-based treatment are few in number, smaller, and do not have financial clout or a media megaphone. They include: the Association of American Physicians and Surgeons (AAPS), has stood against the juggernaut preventing access to HCQ with many efforts, including a lawsuit against FDA and frontline doctors, primarily independent physicians not employed by hospitals or contracted with insurance companies that dictate treatment protocols doctors are allowed to use.
So what do patients need to do now to advocate for early home treatment if they get sick? Here are steps you can take:
• Print Dr. Mccullough’s article and read about your options before you get sick.
• Give a copy of his article to your doctors and family members.
• Ask your doctor now: “If I get sick with COVID, will you treat me at home.